IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
HUMA
Ticker

HUMA

Congressional Trades
18
by 1 members
Ticker disclosure brief

Congressional disclosure records for HUMA

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Tommy Tuberville
SELL · 2024-05-03
Largest range
$50K – $100K
Tommy Tuberville
Longest observed gap
42d
Tommy Tuberville
Highest 30d vs SPY
-116.3%
Tommy Tuberville
Purchase rows
10
56%
Sale rows
2
11%
Disclosed midpoint
$474K
range estimate
Unique Traders
1
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats0 · 0%
Republicans18 · 100%

Lobbying filings

all →
  • 2026-04-21$50K
    HUMACYTE
    Issues related to Medicare reimbursement for biological products. Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters. Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
  • 2026-01-20$50K
    HUMACYTE
    Issues related to Medicare reimbursement for biological products. Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters. Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.
  • 2025-10-21$50K
    HUMACYTE
    Payment for approved medical devices. Payment for approved medical devices. Payment for approved medical devices.
  • 2025-10-20$0
    HUMACYTE
    Payment for approved medical devices. Payment for approved medical devices. Payment for approved medical devices.
  • 2025-10-14$0
    HUMACYTE
    Trauma care
  • 2025-07-13$10K
    HUMACYTE
    Trauma care
  • 2025-04-21$10K
    HUMACYTE
    Trauma care
  • 2025-04-21$0
    HUMACYTE INC.
  • 2025-01-19$10K
    HUMACYTE
    Trauma care
Loading trade analytics…

All Disclosed Trades

Page 1 · 18 of 18 shown
DateMemberActionAmountObserved GapReceipt
2024-05-03RTommy TubervillePARTIAL_SELL$15K – $50K42dreceipt →
2024-05-03RTommy TubervillePARTIAL_SELL$15K – $50K42dreceipt →
2024-05-03RTommy TubervilleSELL$1K – $15K42dreceipt →
2024-05-03RTommy TubervilleSELL$1K – $15K42dreceipt →
2024-04-30RTommy TubervillePARTIAL_SELL$50K – $100K15dreceipt →
2024-04-30RTommy TubervillePARTIAL_SELL$50K – $100K15dreceipt →
2024-03-21RTommy TubervilleBUY$15K – $50K26dreceipt →
2024-03-21RTommy TubervilleBUY$1K – $15K26dreceipt →
2024-03-21RTommy TubervilleBUY$1K – $15K25dreceipt →
2024-03-21RTommy TubervilleBUY$15K – $50K25dreceipt →
2024-03-21RTommy TubervilleBUY$15K – $50K25dreceipt →
2024-03-21RTommy TubervilleBUY$1K – $15K25dreceipt →
2024-02-12RTommy TubervilleBUY$15K – $50K32dreceipt →
2024-02-12RTommy TubervilleBUY$15K – $50K32dreceipt →
2024-01-19RTommy TubervillePARTIAL_SELL$1K – $15K27dreceipt →
2024-01-19RTommy TubervillePARTIAL_SELL$1K – $15K26dreceipt →
2022-03-30RTommy TubervilleBUY$15K – $50K516dApparent delayreceipt →
2023-07-25RTommy TubervilleBUY$1K – $15K34dreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.